Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 14,085 1.100% | -56,910 (-80.16%) | Filing History |
| 2024-02-14 1:12 pm Sale | 2023-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Checkpoint Capital L.P. | 0 0.000% | -61,731 (Position Closed) | Filing History |
| 2024-02-14 09:19 am Purchase | 2023-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Lynx1 Capital Management LP | 122,198 9.900% | 51,841 (+73.68%) | Filing History |
| 2024-02-02 09:59 am Sale | 2023-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund L.P. | 0 0.000% | -50,000 (Position Closed) | Filing History |
| 2023-08-17 4:49 pm Unchanged | 2023-08-10 | 13D | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,623 20.800% | 0 (Unchanged) | Filing History |
| 2023-06-09 5:40 pm Purchase | 2023-06-01 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Checkpoint Capital L.P. | 61,731 6.000% | 61,731 (New Position) | Filing History |
| 2023-05-22 4:47 pm Purchase | 2023-05-11 | 13D | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,623 22.000% | 161,447 (+167.87%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Lynx1 Capital Management LP | 70,357 7.600% | 22,549 (+47.17%) | Filing History |
| 2023-02-14 11:28 am Purchase | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 70,995 7.500% | 16,954 (+31.37%) | Filing History |
| 2023-02-13 8:14 pm Purchase | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 96,176 9.990% | 3,593 (+3.88%) | Filing History |
| 2023-02-10 4:20 pm Unchanged | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Seagen Inc. SGEN | 46,327 5.000% | 0 (Unchanged) | Filing History |
| 2023-02-10 10:22 am Unchanged | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | ASTRAZENECA PLC AZN | 44,803 4.800% | 0 (Unchanged) | Filing History |
| 2023-01-27 5:02 pm Purchase | 2023-01-25 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund L.P. | 50,000 5.400% | 37,500 (+300.00%) | Filing History |
| 2023-01-26 5:01 pm Sale | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund L.P. | 12,500 1.300% | -36,061 (-74.26%) | Filing History |
| 2022-10-24 4:57 pm Purchase | 2022-10-13 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Lynx1 Capital Management LP | 47,808 5.100% | 47,808 (New Position) | Filing History |
| 2022-02-14 3:20 pm Sale | 2021-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Aquilo Capital Management LLC | 54,041 5.900% | -5,988 (-9.98%) | Filing History |
| 2022-02-14 1:56 pm Purchase | 2021-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 92,583 9.990% | 22,563 (+32.22%) | Filing History |
| 2022-02-14 06:22 am Sale | 2021-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Citadel Advisors LLC | 40,760 4.500% | -776 (-1.87%) | Filing History |
| 2022-02-14 06:08 am Unchanged | 2021-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Nussbaum Ran | 44,643 4.960% | 0 (Unchanged) | Filing History |
| 2022-01-27 4:30 pm Purchase | 2022-01-24 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund L.P. | 48,561 5.400% | 48,561 (New Position) | Filing History |